Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates

Molecules. 2022 Apr 15;27(8):2568. doi: 10.3390/molecules27082568.

Abstract

Cancer is a complex pathology that causes a large number of deaths worldwide. Several risk factors are involved in tumor transformation, including epigenetic factors. These factors are a set of changes that do not affect the DNA sequence, while modifying the gene's expression. Histone modification is an essential mark in maintaining cellular memory and, therefore, loss of this mark can lead to tumor transformation. As these epigenetic changes are reversible, the use of molecules that can restore the functions of the enzymes responsible for the changes is therapeutically necessary. Natural molecules, mainly those isolated from medicinal plants, have demonstrated significant inhibitory properties against enzymes related to histone modifications, particularly histone deacetylases (HDACs). Flavonoids, terpenoids, phenolic acids, and alkaloids exert significant inhibitory effects against HDAC and exhibit promising epi-drug properties. This suggests that epi-drugs against HDAC could prevent and treat various human cancers. Accordingly, the present study aimed to evaluate the pharmacodynamic action of different natural compounds extracted from medicinal plants against the enzymatic activity of HDAC.

Keywords: cancer; epidrugs; epigenetic; histone deacetylases; natural compounds.

Publication types

  • Review

MeSH terms

  • Epigenesis, Genetic
  • Epigenomics
  • Histone Deacetylase Inhibitors / pharmacology
  • Histone Deacetylase Inhibitors / therapeutic use
  • Histone Deacetylases / metabolism
  • Humans
  • Neoplasms* / pathology
  • Plants, Medicinal* / metabolism
  • Protein Processing, Post-Translational

Substances

  • Histone Deacetylase Inhibitors
  • Histone Deacetylases